HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A recombined fusion protein PTD-Grb2-SH2 inhibits the proliferation of breast cancer cells in vitro.

Abstract
The growth factor receptor bound protein 2 (Grb2) is one of the affirmative targets for cancer therapy, especially for breast cancer. In this study, we hypothesized the Src-homology 2 (SH2) domain in Grb2 may serve as a competitive protein-binding agent to interfere with the proliferation of breast cancer cells in vitro. We designed, constructed, expressed and purified a novel fusion protein containing the protein transduction domain (PTD) and Grb2-SH2 domain (we named it after PTD-Grb2-SH2). An immunofluorescence assay was used to investigate the location of PTD-Grb2-SH2 in cells. MTT assay and EdU experiments were applied to detect the proliferation of breast cancer cells. The ultra-structure was observed using transmission electron microscopy. Flow cytometry was used to determine the cytotoxicity of PTD-Grb2-SH2 on cell proliferation. We successfully obtained the PTD-Grb2-SH2 fusion protein in soluble form using a prokaryotic expression system. The new fusion protein successfully passed through both the cellular and nuclear membranes of breast cancer cells. The MTT assay showed that PTD-Grb2-SH2 exhibited significant toxicity to breast cancer cells in a dose- and time-dependent manner in vitro. EdU identified the decreased proliferation rates in treated MDA-MB-231 and SK-BR-3 cells. Observation by transmission electron microscopy and flow cytometry further confirmed the cytotoxicity as apoptosis. Our results show that the HIV1-TAT domain is a useful tool for transporting a low molecular weight protein across the cell membrane in vitro. The PTD-Grb2-SH2 may be a novel agent for breast cancer therapy.
AuthorsJikai Yin, Zhongliang Cai, Li Zhang, Jian Zhang, Xianli He, Xilin Du, Qing Wang, Jianguo Lu
JournalInternational journal of oncology (Int J Oncol) Vol. 42 Issue 3 Pg. 1061-9 (Mar 2013) ISSN: 1791-2423 [Electronic] Greece
PMID23314696 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • GRB2 Adaptor Protein
  • GRB2 protein, human
  • Recombinant Fusion Proteins
Topics
  • Apoptosis
  • Breast Neoplasms (metabolism)
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Survival
  • Female
  • GRB2 Adaptor Protein (genetics, metabolism)
  • Gene Expression
  • Humans
  • Protein Structure, Tertiary
  • Recombinant Fusion Proteins (biosynthesis, genetics, metabolism)
  • Transduction, Genetic
  • src Homology Domains (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: